Evaluating the efficacy of the praziquantel dose pole for schistosomiasis treatment: A multi-country systematic review
Table 5
Community-based treatment for adults (ages15-49), categorized by dose (Insufficient, Acceptable, Optimal, and Excessive), using the WHO dose pole with matched ages (15-49) from two studies in Mozambique and Zimbabwe.